We are live on
!
Find out more
RCI
RS Crum Inc Portfolio holdings
AUM
$517M
1-Year Est. Return
16.68%
This Fund
S&P 500
This Quarter
Est. Return
+4.92%
1 Year Est. Return
+16.68%
3 Year Est. Return
+37.83%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$367M
AUM Growth
+$42.7M
(+13%)
Cap. Flow
+$27.6M
Cap. Flow
% of AUM
7.51%
Top 10 Holdings %
Top 10 Hldgs %
75.19%
Holding
82
New
1
Increased
25
Reduced
30
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFUS
Dimensional US Equity ETF
DFUS
|
+$10.8M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$5.44M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$4.8M |
| 4 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$2.8M |
| 5 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.46M |
| 2 |
KE
Kimball Electronics
KE
|
+$245K |
| 3 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
+$193K |
| 4 |
iShares Global REIT ETF
REET
|
+$166K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$70.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.33% |
| 2 | Industrials | 1.38% |
| 3 | Communication Services | 1.27% |
| 4 | Energy | 1.26% |
| 5 | Healthcare | 0.76% |
Similar funds
AAM
WP
SC
LHC
WPP
TAM
OIS
CI
RS Crum Inc's Q1 2024 Portfolio in Review
As of Q1 2024, RS Crum Inc held 82 positions worth $367M, up 13% from $324M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
RS Crum Inc deployed $27.6M of net new capital in Q1 2024, opening 1 new position and adding to 25 existing holdings. Its largest new stake was Calidi Biotherapeutics: 90 shares worth $6.13K.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.5% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $1.46M trimmed.
- RS Crum Inc's largest Q1 2024 buy was Calidi Biotherapeutics: 90 shares worth $6.13K.
- RS Crum Inc added most to Dimensional US Equity ETF in Q1 2024, an estimated $10.8M increase.
- RS Crum Inc's biggest Q1 2024 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $1.46M.
- RS Crum Inc fully exited Kimball Electronics in Q1 2024, selling an estimated $245K.
- RS Crum Inc's ten largest holdings make up 75% of its $367M portfolio in Q1 2024.
- RS Crum Inc opened 1 new position and closed 1 in Q1 2024.
- RS Crum Inc's portfolio value rose 13% quarter-over-quarter to $367M.
Based on RS Crum Inc's 13F filing for Q1 2024, filed 13 May 2024.